Hers and Liraglutide: Where the GLP-1 Compound Fits

This article sits in the PlexusDx Education Hub, our collection of evidence-based guidance on GLP-1 receptor agonists, weight-management protocols, and the genetics behind every metabolic decision. Browse all Peptides & GLP-1 education

An independent editorial review. PlexusDx has no commercial relationship with Hers or its parent, and no affiliate links or compensation are involved.

Hers is one of many telehealth programs in the GLP-1 and weight-management space. This review centers on liraglutide, where the compound sits within the GLP-1 receptor agonist class, how a telehealth program of this kind would handle it, and the genetic context it leaves untouched. Fair-balance framing, not a buying recommendation. Current as of April 2026.

Where liraglutide sits in the GLP-1 class

Liraglutide is a GLP-1 receptor agonist, one of the established members of that class alongside semaglutide and dulaglutide. Programs like Hers, the women's brand of Hims & Hers Health, operate as subscription telehealth, and which specific GLP-1 agonists they offer varies by brand and changes over time. Whether liraglutide is available in a given program, and on what terms, is something to confirm directly on Hers's official website.

How a telehealth program handles a GLP-1 agonist

The mechanics are the same regardless of which agonist is prescribed: you complete an intake, a licensed clinician reviews it and decides on eligibility, and a prescription is routed to a retail pharmacy for an FDA-approved brand product or to a 503A compounding pharmacy for a compounded preparation, followed by titration support. Provider type, pharmacy partner, and subscription structure are where individual programs differ.

The evidence base for GLP-1 receptor agonists

As a class, GLP-1 receptor agonists, semaglutide, liraglutide, and dulaglutide, share a mechanism, while tirzepatide adds GIP activity as a dual agonist. The clinical record is public: STEP studied semaglutide for weight management (The New England Journal of Medicine, 2021), SURMOUNT studied tirzepatide for weight management (NEJM, 2022), and SURMOUNT-OSA examined tirzepatide in obstructive sleep apnea (NEJM, 2024). Trial designs and populations differ, and results vary from person to person.

Pricing and access for a GLP-1 program

Published pricing for Hers is on its own website, and totals depend on the compound, the subscription tier, and whether dispensing is brand or compounded. Across the telehealth GLP-1 market as of April 2026, monthly totals typically range from roughly $200 to $700+, with wide variance. Confirm any figure at Hers's official website before committing.

The genetic context liraglutide cannot supply

A prescription for any GLP-1 agonist still leaves one thing unmeasured. Telehealth programs like this one do not examine the upstream genetic architecture that shapes every GLP-1 response. Variants in FTO (the fat-mass and obesity-associated gene), GLP1R (the GLP-1 receptor gene, the direct target of every GLP-1 compound), MC4R (a melanocortin receptor central to satiety and energy balance), and TCF7L2 (a transcription factor tied to glucose homeostasis and GLP-1 secretion) map the baseline metabolic terrain any compound acts on. These are pathway-level markers. They do not predict response to a specific medication, but they describe the biology a clinician is prescribing into, context a prescription alone never captures.

PlexusDx offers semaglutide and tirzepatide through its Weight Management Protocols, available as Semaglutide Injection, Semaglutide Oral, Tirzepatide Injection, and Tirzepatide Oral. What distinguishes the approach is that upstream genetic context. Before starting any GLP-1 pathway protocol, the Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights, including variants in FTO and MC4R, and TCF7L2 that shape your baseline GLP-1, appetite-regulation, and energy-balance biology. Reading that profile alongside the protocol is the test before you invest approach, turning guesswork into an informed conversation with your healthcare provider.

Not affiliated: PlexusDx is not affiliated with Hers and has no commercial relationship with the companies reviewed in this article.

Related reading on PlexusDx: Where To Buy Victoza, Where To Get Victoza, Victoza Cost, Victoza Dosing.

Disclaimer: This article is educational. PlexusDx is not affiliated with Hers and has no commercial relationship with the companies reviewed. PlexusDx offers semaglutide and tirzepatide through its own Weight Management Protocols, and this review compares approaches in the GLP-1 telehealth space. The Precision Peptide Genetic Test analyzes how your genes influence peptide-related biological pathways; it does not predict response to any specific medication. Consult a qualified healthcare provider before beginning any peptide protocol.

Compare the PlexusDx approach: see the Weight Management Protocols, semaglutide and tirzepatide paired with the genetic context most telehealth programs omit. Or start upstream and take the Precision Peptide Genetic Test to understand your GLP-1 pathway first.

Frequently Asked Questions About Hers and Liraglutide

Does Hers offer liraglutide?

Which GLP-1 agonists a program carries varies by brand and changes over time, so availability of liraglutide specifically should be confirmed on the brand's own site. Telehealth programs in this category generally dispense either FDA-approved brand products or compounded preparations, depending on the pharmacy pathway.

How does liraglutide differ from weekly GLP-1 agonists?

Liraglutide is a GLP-1 receptor agonist within the same class as semaglutide and dulaglutide. Agonists in this class differ in their administration schedules and formulations. Because that varies by product, follow the prescribing information for any specific compound rather than assuming a single standard applies.

What is the difference between brand and compounded liraglutide?

Brand-name products are FDA-approved and dispensed by retail pharmacies, while compounded preparations are made by 503A compounding pharmacies for individual patients. Availability, formulation, and cost differ between the two, so confirm which pathway a program uses before drawing conclusions about price or supply.

Do genetics affect liraglutide response?

Pathway-level variants in FTO and MC4R, and TCF7L2 shape baseline GLP-1, appetite, and energy-balance biology across the whole receptor-agonist class. They do not predict response to liraglutide specifically, but they describe the terrain any GLP-1 agonist acts on, context a prescription alone omits.

This article is part of the PlexusDx Education Hub. Browse all Peptides & GLP-1 education